Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
By Pat Rizzuto
Sept. 16 — Less than 1 percent of the nearly $820 million the U.S. government invested in synthetic biology over six years has supported research on ethical, legal and social issues, according to a Woodrow Wilson Center report released Sept. 16.
Funding by various Department of Defense agencies has made up the majority, or 67 percent, of all U.S. investments between 2008 and 2014, according to the report, “U.S. Trends in Synthetic Biology Research Funding.”
The National Institutes of Health has awarded more than $120 million in synthetic biology-related grants since 2008, the report said. It appears that the NIH does not use the term “synthetic biology” in the same context as other agencies, the report said, so this number could be artificially low.
Other government agencies providing significant funds for synthetic biology research since 2008 are the departments of Agriculture and Energy and the National Science Foundation.
The report said synthetic biology research funding is increasing internationally. Last year, research investments by the European Commission and research agencies in the UK exceeded non-defense spending in the U.S., the report found.
The research spending comes at a time of growing interest in synthetic biology, particularly surrounding the potential presented by new gene-editing techniques, according to the report. Recent research by the industry group SynBioBeta indicated that, so far in 2015, synthetic biology companies raised half a billion dollars—more than the total investments in 2013 and 2014 combined.
The Environmental Protection Agency, which would have oversight of chemicals and pesticides developed through synthetic biology, is not spending any money addressing the risks this emerging technology may engender, a spokesman for the Woodrow Wilson Synthetic Biology Project told Bloomberg BNA Sept. 15.
The Woodrow Wilson Center released the report two weeks before the EPA holds a Sept. 30 workshop to discuss guidance it is developing for the use of genetically modified algae to manufacture chemicals.
To contact the reporter on this story: Pat Rizzuto in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Larry Pearl at email@example.com
The report on synthetic biology funding trends is available at http://www.synbioproject.org/publications/u.s-trends-in-synthetic-biology-research-funding/.
Details on EPA workshop and the guidance the agency is developing are available at https://projects.erg.com/conferences/oppt/agenda.htm.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)